views
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
The global Preclinical Imaging market is projected to grow at a compound annual growth rate (CAGR) of 5.1% between 2024 and 2034. By 2034, the market's revenue is expected to reach USD 8.36 billion, following a steady growth trajectory. In 2024, the market size is estimated to be valued at USD 4.19 billion.
Request Sample Copy: https://wemarketresearch.com/reports/request-free-sample-pdf/preclinical-imaging-market/1628
The global preclinical imaging market report highlights cutting-edge imaging technologies utilized in preclinical research to study diseases, facilitate drug development, and assess biological processes in animal models. These technologies play a vital role in translational research by bridging the gap between basic science and clinical applications. Preclinical imaging enables the in vivo visualization of molecular-level biological processes in animal models, providing valuable insights into human diseases.
The global preclinical imaging market encompasses a key segment of the healthcare and biotechnology industry, focusing on the development, production, and application of imaging technologies and systems for preclinical research. This involves visualizing biological processes at the molecular, cellular, tissue, or whole-animal level, primarily in non-human subjects, to support advancements in drug discovery, development, and translational research.
Market Scope
Report Attributes
Market Size in 2024: USD 4.19 Billion
Market Forecast by 2034: USD 8.36 Billion
CAGR % (2024-2034): 5.1%
Base Year: 2023
Historic Data: 2019-2023
Forecast Period: 2024-2034
Report USP: Production, Consumption, company share, company heatmap, company production capacity, growth factors, and more
Segments Covered: By Product, By Modality, By Application, By End-Use, and By Region
Regional Scope: North America, Europe, APAC, Latin America, and Middle East and Africa
Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Benelux, Nordic Countries, Russia, China, India, Japan, South Korea, Australia, Indonesia, Thailand, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Egypt, South Africa, Nigeria
Market Segments
By Product:
CT Imaging
MRI Imaging
PET/SPECT Imaging
Multi-modal Imaging
Optical Imaging
Ultrasound Imaging
Photoacoustic Imaging
Reagents
Others
By Application:
Drug Discovery and Development
Disease Research
Others
By Modality:
Standalone
Integrated
By End-Use:
Comments
0 comment